<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/95524E5B-E175-4691-AADA-C3E30E53A1F7"><gtr:id>95524E5B-E175-4691-AADA-C3E30E53A1F7</gtr:id><gtr:name>University of Cologne</gtr:name><gtr:address><gtr:line1>Fachbereich Wirtschaft</gtr:line1><gtr:line2>Claudrusstra?e 1</gtr:line2><gtr:line4>D-50678 Cologne</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0F15002C-C70C-4AD9-B432-E950F6B2FDFD"><gtr:id>0F15002C-C70C-4AD9-B432-E950F6B2FDFD</gtr:id><gtr:name>European Institute of Oncology</gtr:name><gtr:address><gtr:line1>Via Ripamonti 435</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/95524E5B-E175-4691-AADA-C3E30E53A1F7"><gtr:id>95524E5B-E175-4691-AADA-C3E30E53A1F7</gtr:id><gtr:name>University of Cologne</gtr:name><gtr:address><gtr:line1>Fachbereich Wirtschaft</gtr:line1><gtr:line2>Claudrusstra?e 1</gtr:line2><gtr:line4>D-50678 Cologne</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0F15002C-C70C-4AD9-B432-E950F6B2FDFD"><gtr:id>0F15002C-C70C-4AD9-B432-E950F6B2FDFD</gtr:id><gtr:name>European Institute of Oncology</gtr:name><gtr:address><gtr:line1>Via Ripamonti 435</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1E2D89E7-4F85-4BE0-9DBD-A5463A7AE7A1"><gtr:id>1E2D89E7-4F85-4BE0-9DBD-A5463A7AE7A1</gtr:id><gtr:firstName>Irina</gtr:firstName><gtr:surname>Udalova</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501087"><gtr:id>01D677BD-2C0F-4DC9-AAB8-3C8844B82651</gtr:id><gtr:title>DISSECTING THE FUNCTION OF INDIVIDUAL NF-kappaB SUBUNITS IN INFLAMMATION</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501087</gtr:grantReference><gtr:abstractText>Inflammation is a normal physiological response to infection and injury, but can lead to extensive tissue damage and disability when elicited in excess. Pathological consequences of sustained inflammatory response include variety of autoimmune diseases, such as rheumatoid arthritis, Crohn?s disease, ankylosing spondylitis and multiple sclerosis. A sustained inflammatory response is often linked to the break down in regulation of production of inflammatory molecules. In a normal self-resolving body response to infection or injury inflammatory molecules are produced for a defined period of time, while in chronic autoimmune conditions their production is prolonged. 
The production of many inflammatory molecules is controlled by a key family of regulatory proteins called NF-kappaB. All five NF-kappaB proteins are present at the site of inflammation and are active, but at different times. Why there are five similar but not identical NF-kappaB proteins, why they come to and leave the site of inflammation at different times and how they control the level and the length of production of inflammatory molecules is a subject of this investigation. 
Understanding how each NF-kappaB protein functions and what molecules it regulates is important for the development of a new generation of therapeutic approaches. These would only target specific cellular events without interfering with the global host defence mechanisms. It will also help scientists to better understand why we have so many families of ostensibly similar proteins and what specific functions they hold.
The research will be carried out by Dr Irina Udalova at the Kennedy Institute of Rheumatology, Imperial College, and will be laboratory based using novel genomic techniques and computational methods. The proposed novel techniques will replace the use of animals in research. Results generated in this study will be communicated through peer-reviewed scientific journals and through annual reports from the Kennedy Institute and presented at scientific meetings.</gtr:abstractText><gtr:technicalSummary>NF-kappaB plays a pivotal role in immunity and inflammation and is considered to be a prime candidate for drug development. The fundamental goal of this proposal is to identify NF-kappaB subunit specific regulatory events in a human immune response. I propose to systematically determine the genes whose expression is dependent on specific NF-kappaB dimeric complexes in primary human dendritic cells exposed to bacterial products and to characterise the functional genetic elements which select these complexes. The project builds on my existing expertise and available genomic and computational approaches and develops new ways for studying transcriptional gene regulation, such as the genetic manipulation of human cells, previously achievable only in animal models. It will generate new reagents for quantitative analysis of cellular responses available to the scientific community. The identification of NF-kappaB subunit specific regulatory events will provide an alternative path for the development of targeted therapeutic strategies for treating immune disorders.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-24</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-25</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>323060</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cologne</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>MP</gtr:description><gtr:id>7D744C76-F006-4A9E-AFE2-1C98117885C6</gtr:id><gtr:impact>Grants: 1. FP7-EU grant 222008 &amp;quot;Genomic determinants of inflammation&amp;quot;</gtr:impact><gtr:outcomeId>35DB67D47E7-1</gtr:outcomeId><gtr:partnerContribution>providing with reagents (cells with targeted disruption of NFkB RelA)</gtr:partnerContribution><gtr:piContribution>analysis of gene expression in provided cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>RC</gtr:description><gtr:id>17769DB6-369D-4EB6-99EC-F7D633838E85</gtr:id><gtr:impact>Publications: 1. PMID: 17785540 Grants 1. MRC grant application G0900965 - scores received 9, 9, 7, 7 - marked as of high priority - invited to re-submit in the next round 2. Wellcome Trust grant application WT090847 &amp;quot;THE ROLE OF TRANSPOSABLE ELEMENTS IN REGULATION OF NF-KAPPAB DEPENDENT GENES&amp;quot; - decision pending</gtr:impact><gtr:outcomeId>E2EFEC63606-1</gtr:outcomeId><gtr:partnerContribution>bioinformatic support</gtr:partnerContribution><gtr:piContribution>Setting up the question; generating experimental data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Kennedy Institute of Rheumatology</gtr:department><gtr:description>KM</gtr:description><gtr:id>339FEB23-D7D0-4BAB-B2C9-995DF725DACB</gtr:id><gtr:impact>Publications: 1. Fui G. Goh, Anna M. Piccinini, Thomas Krausgruber, Irina A. Udalova and Kim S. Midwood. &amp;quot;Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation&amp;quot;. Journal of Immunology. In press. Grants: 1. Wellcome Trust grant application WT14378 &amp;quot;Controlling the expression of endogenous danger signals during inflammation&amp;quot; - decision pending</gtr:impact><gtr:outcomeId>A3F661C802A-1</gtr:outcomeId><gtr:partnerContribution>Expansion of our research scope into the field of extracellular matrix</gtr:partnerContribution><gtr:piContribution>Providing with expertise in gene regulation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>JR</gtr:description><gtr:id>EF88C633-D4BD-482C-B2C4-ABB19F07E0E2</gtr:id><gtr:impact>Publications: 1. PMID: 17785540 2. PMID: 17785540 3. PMID: 16888364 4. Linnell J, Mott R, Field S, Kwiatkowski DP, Ragoussis J, Udalova IA. Quantitative high-throughput analysis of transcription factor binding specificities. Nucleic Acids Res. 2004 Feb 27;32(4):e44. PMID: 14990752 Grants: 1. FP7-EU grant 222008 &amp;quot;Genomic determinants of inflammation&amp;quot; 2. MRC collaborative grant G0700818</gtr:impact><gtr:outcomeId>2D2C762FC97-1</gtr:outcomeId><gtr:partnerContribution>Using the genomic platform developed in this collaboration, Ragoussis team has produced our analysis of their functional properties and conservation.</gtr:partnerContribution><gtr:piContribution>I have initially set up and developed high throughput analysis of transcription factor - DNA interactions in vitro, further optimised and developed by the collaborator's team.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Institute of Oncology (IEO)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>GN</gtr:description><gtr:id>59CB8117-2FC0-4C37-A085-88AAACD91668</gtr:id><gtr:impact>Grants: 1. FP7-EU grant 222008 &amp;quot;Genomic determinants of inflammation&amp;quot; 2. Royal Society joint grant &amp;quot;Examining DNA sequence selectivity by alternative NF-kappaB proteins&amp;quot; 3. Horizon 2020 PCH03 proposal &amp;quot;Unifying basis of Chronic Inflammatory Diseases&amp;quot; submitted</gtr:impact><gtr:outcomeId>0E6A5DCEBD8-1</gtr:outcomeId><gtr:partnerContribution>Intellectual contribution to the aspects of gene regulation; transferring chromatin immunoprecipitation and 3C techniques</gtr:partnerContribution><gtr:piContribution>Intellectual contribution to DNA-protein interactions and genome analysis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>RM</gtr:description><gtr:id>A7DE87F6-3A85-4AB4-B0BD-FD75DE3E81F5</gtr:id><gtr:impact>Grants: 1. MRC NIA G0501087 2. MRC collaborative grant G0700818</gtr:impact><gtr:outcomeId>61604486D98-1</gtr:outcomeId><gtr:partnerContribution>Computational support</gtr:partnerContribution><gtr:piContribution>Setting up the question; generating experimental data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>INTAS genomics and proteomics workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0418DBCB-64AE-4E34-B3D0-7E53163349F6</gtr:id><gtr:impact>presentation &amp;quot;Quantitative analysis of protein-DNA interactions: application to functional genomics&amp;quot;

education of students and public in Ukraine</gtr:impact><gtr:outcomeId>E3D21AC0B7E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Aggressive Lymphoma symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>47BFF093-EE74-40FB-9EAA-4EA62BE293ED</gtr:id><gtr:impact>&amp;quot;Functional effects of genetic polymorphisms: quantitative analysis of TF-DNA interactions&amp;quot; 30 min presentation at Aggressive Lymphoma symposium (Gottingen, Germany)

education of medical doctors</gtr:impact><gtr:outcomeId>D9343B4AFF3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>208121</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Collaborative Grant</gtr:description><gtr:end>2009-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>733A74B8-2076-4248-B576-95418C1E774A</gtr:id><gtr:outcomeId>B78E68712050</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>425000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EC FP7 (HEALTH-2.1.2-5)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>43A4855D-E368-4479-B703-A88B4B86B1C9</gtr:id><gtr:outcomeId>784277C7DB60</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>332796</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CO-REGULATION OF MACROPHAGE INFLAMMATORY PHENOTYPE BY IRF5 AND RELA</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>141EB1AE-50A5-4F02-9558-730A09A0E765</gtr:id><gtr:outcomeId>LeA4erHHcTT0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>optimized reagents for NF-kappaB inhibition in human cells; cell lines with depleted NF-kappaB levels</gtr:description><gtr:id>14DE454E-508B-4CA5-974A-C33498118BAD</gtr:id><gtr:impact>useful tool for gene regulation studies</gtr:impact><gtr:outcomeId>84A41343A1A</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>RNAi</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>DNA constructs expressing various NF-kappaB subunits</gtr:description><gtr:id>2C4B31E7-61BD-40AB-B2EE-4E5307187C54</gtr:id><gtr:impact>useful tools for analysis of gene regulation</gtr:impact><gtr:outcomeId>4159F3600C8</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>NF-kappaB expression plasmids</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>database of the genes regulated by NF-kappaB</gtr:description><gtr:id>4FD170DA-CCAF-4BA5-976C-9A2BCA908A0C</gtr:id><gtr:impact>framework for genome-wide analysis of gene expression in inflammation</gtr:impact><gtr:outcomeId>344C4FE8198</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>NF-kappaB genes</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DEE4BBD9-4016-4EF5-8035-40436800ACB4</gtr:id><gtr:title>Functional conservation of Rel binding sites in drosophilid genomes.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed9390949faec02f0dcc7c3c268a5a18"><gtr:id>ed9390949faec02f0dcc7c3c268a5a18</gtr:id><gtr:otherNames>Copley RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>A1578DBB053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83536419-E49B-46D7-9877-A915BABDC7F8</gtr:id><gtr:title>Quantitative measurement of cytokine expression in synoviocytes derived from rheumatoid arthritis patients.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b596ee223e343a1e6b91bd673ff6c818"><gtr:id>b596ee223e343a1e6b91bd673ff6c818</gtr:id><gtr:otherNames>Thomson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>517199E07D3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62EFC94D-CC5E-4506-8B19-80FF32C394F5</gtr:id><gtr:title>The role of transposable elements in the regulation of IFN-lambda1 gene expression.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/963931876296757278bc16f740887772"><gtr:id>963931876296757278bc16f740887772</gtr:id><gtr:otherNames>Thomson SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>047FA169019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C28712CB-06D4-4350-A37F-D6E815C9E55C</gtr:id><gtr:title>Detecting and modulating the NF-kB activity in human immune cells: generation of human cell lines with altered levels of NF-kappaB.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/905e16968f95c6747894aa49589fff43"><gtr:id>905e16968f95c6747894aa49589fff43</gtr:id><gtr:otherNames>Goh FG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>0BA52BE94FD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE9887C2-37C0-42CA-9658-52932FDD2852</gtr:id><gtr:title>Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/905e16968f95c6747894aa49589fff43"><gtr:id>905e16968f95c6747894aa49589fff43</gtr:id><gtr:otherNames>Goh FG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>e2jU7eNYVGQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC8B431F-A36F-4D30-8C25-695D7B96C65E</gtr:id><gtr:title>Beyond the enhanceosome: cluster of novel ?B sites downstream of the human IFN-? gene is essential for lipopolysaccharide-induced gene activation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/905e16968f95c6747894aa49589fff43"><gtr:id>905e16968f95c6747894aa49589fff43</gtr:id><gtr:otherNames>Goh FG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>WWz4pxWrYNo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A394CAAE-7FA8-4222-8299-9B93791EBC21</gtr:id><gtr:title>Accuracy and reproducibility of protein-DNA microarray technology.</gtr:title><gtr:parentPublicationTitle>Advances in biochemical engineering/biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f51c7b764f2d48fd102a21e4374a14d1"><gtr:id>f51c7b764f2d48fd102a21e4374a14d1</gtr:id><gtr:otherNames>Field S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0724-6145</gtr:issn><gtr:outcomeId>585d589556b6c5.41205972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B01FE90-E82E-4891-B0BD-D6DCA171987C</gtr:id><gtr:title>Quantitative profiling of protein-DNA binding on microarrays.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c5c36707a821af68ece955041f71fc9"><gtr:id>4c5c36707a821af68ece955041f71fc9</gtr:id><gtr:otherNames>Ragoussis J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>6D8F0ED6436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88F7A54D-3C20-4678-A4FA-41FA14013FEB</gtr:id><gtr:title>Cross-species analysis reveals evolving and conserved features of the nuclear factor ?B (NF-?B) proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1d84a4833493a5f2de6c0e6f9c85b75"><gtr:id>b1d84a4833493a5f2de6c0e6f9c85b75</gtr:id><gtr:otherNames>Ryzhakov G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15019_29_23508954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>245172B6-4409-45C9-A67A-EC2D9034534D</gtr:id><gtr:title>Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/905e16968f95c6747894aa49589fff43"><gtr:id>905e16968f95c6747894aa49589fff43</gtr:id><gtr:otherNames>Goh FG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>ef3Ze1PWEM7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501087</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>